Costing Taxpayers Billions. Terminally ill patients left Medicare Advantage for traditional Medicare at double the rate o ...

We recently published a list of 11 Best Performing Large Cap Stocks So Far in 2025. In this article, we are going to take a ...

An unexpected disclosure rocked the health insurance world last week: CVS Health decided it was pulling out of the Affordable ...

The legislation would ensure Medicare beneficiaries have access to care and services provided by pharmacists within state ...

Gilead to Pay $202 Million to Settle DOJ Claims Over Speaker Program Kickbacks - Gilead Sciences, Inc. has agreed to pay $202 ...

On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...

Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced the Company has secured multiple market access ...

Biocon Biologics secures market access agreements for Yesintek, a biosimilar to Stelara, for treating autoimmune diseases in ...

Biocon advanced 3.17% to Rs 328.75 after Biocon Biologics (BBL) secures multiple market access agreements in the United States for Yesintek (ustekinumab-kfce), its biosimilar to Stelara (ustekinumab), ...

Biocon Biologics secures multiple market access agreements in the US for its biosimilar, Yesintek, for treating Crohn's ...

Shilpa Medicare Ltd., incorporated in the year 1987, is a company (having a market cap of Rs 6,165.23 Crore) operating in Pharmaceuticals sector. Shilpa Medicare Ltd. key Products/Revenue Segments ...